Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Fluticasone Furoate/GW642444 on HPA Axis in Asthma
2009-017669-44Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate + vilanterol in asthma (4 arms), sponsored by GSK. Primary endpoint: Twenty-four hour weighted mean serum cortisol. Started Jan 2010; status: completed.
02
Drugs
fluticasone propionate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-017669-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017669-44.